211 related articles for article (PubMed ID: 9207459)
21. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
22. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
23. Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Vitolo U; Botto B; Capello D; Vivenza D; Zagonel V; Gloghini A; Novero D; Parvis G; Calvi R; Ariatti C; Milan I; Bertini M; Boccomini C; Freilone R; Pregno P; Orsucci L; Palestro G; Saglio G; Carbone A; Gallo E; Gaidano G
Leukemia; 2002 Feb; 16(2):268-75. PubMed ID: 11840294
[TBL] [Abstract][Full Text] [Related]
24. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
25. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
[TBL] [Abstract][Full Text] [Related]
26. Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR.
Noriega MF; De Brasi C; Narbaitz M; Slavutsky I
Blood Cells Mol Dis; 2004; 32(1):232-9. PubMed ID: 14757440
[TBL] [Abstract][Full Text] [Related]
27. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
[TBL] [Abstract][Full Text] [Related]
28. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype.
Gaidano G; Lo Coco F; Ye BH; Shibata D; Levine AM; Knowles DM; Dalla-Favera R
Blood; 1994 Jul; 84(2):397-402. PubMed ID: 8025268
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
30. [Detection of bcl-2/JH fusion gene in patients with B cell non-Hodgkin's lymphoma by polymerase chain reaction and its clinical implication].
Feng W; Huang Z
Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):361-3. PubMed ID: 15624333
[TBL] [Abstract][Full Text] [Related]
31. Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma.
Pervez S; Nasir MI; Moatter T; Ahsan A; Haq A; Siddiqui T
J Cancer Res Ther; 2009; 5(4):254-62. PubMed ID: 20160358
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic features, prognosis and etiology of primary non-Hodgkin lymphoma of bone].
Zhou ZY; Shi QL; Zhou XJ; Lan JY; Wang JD; Huang WB; Chen JY; Ma HH; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):90-3. PubMed ID: 17493381
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 molecular analysis in paraffin-embedded biopsies from diffuse large B-cell lymphomas.
De Brasi C; Narbaitz M; Rodriguez A; Larripa I; Slavutsky I
Medicina (B Aires); 2000; 60(3):305-10. PubMed ID: 11050805
[TBL] [Abstract][Full Text] [Related]
34. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation.
de Leval L; Braaten KM; Ancukiewicz M; Kiggundu E; Delaney T; Mankin HJ; Harris NL
Am J Surg Pathol; 2003 Sep; 27(9):1269-77. PubMed ID: 12960812
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.
Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N
Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics of high-grade B-cell lymphomas with rearrangement of MYC, bcl-6 and bcl-2].
Gong JY; Zhang YZ; Zhang JD; Zhang W; Li JQ; Ru K; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):14-18. PubMed ID: 29325245
[No Abstract] [Full Text] [Related]
38. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.
Kramer MH; Hermans J; Parker J; Krol AD; Kluin-Nelemans JC; Haak HL; van Groningen K; van Krieken JH; de Jong D; Kluin PM
J Clin Oncol; 1996 Jul; 14(7):2131-8. PubMed ID: 8683246
[TBL] [Abstract][Full Text] [Related]
40. [Complex diagnosis of follicular lymphomas].
Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
